Wright Medical Group N.V. (NASDAQ: WMGI) and Delcath Systems (OTCMKTS:DCTHD) are both small-cap medical prosthetics companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends and risk.


This table compares Wright Medical Group N.V. and Delcath Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Wright Medical Group N.V. -38.40% -6.27% -1.71%
Delcath Systems -1,278.64% -3,960.73% -165.16%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Wright Medical Group N.V. and Delcath Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wright Medical Group N.V. 0 4 8 0 2.67
Delcath Systems 0 0 0 0 N/A

Wright Medical Group N.V. presently has a consensus target price of $32.22, suggesting a potential upside of 29.93%. Given Wright Medical Group N.V.’s higher probable upside, equities analysts clearly believe Wright Medical Group N.V. is more favorable than Delcath Systems.

Risk & Volatility

Wright Medical Group N.V. has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Comparatively, Delcath Systems has a beta of -0.17, indicating that its stock price is 117% less volatile than the S&P 500.

Earnings and Valuation

This table compares Wright Medical Group N.V. and Delcath Systems’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Wright Medical Group N.V. $690.36 million 3.77 -$432.37 million ($4.74) -5.23
Delcath Systems $1.99 million 0.46 -$17.97 million ($1,554.19) 0.00

Delcath Systems has higher revenue, but lower earnings than Wright Medical Group N.V.. Wright Medical Group N.V. is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.


Wright Medical Group N.V. beats Delcath Systems on 9 of the 10 factors compared between the two stocks.

About Wright Medical Group N.V.

Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Company’s business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Company’s products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.

About Delcath Systems

Delcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company’s system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company’s focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.